CADDRA is a Canadian non-profit member association for medical and health care professionals, along with researchers, who assess, treat and/or study ADHD. | |
Conference Keynote Speaker |
 |  | Alexandra Philipsen, MD is Director and W3 Professor of the Department of Psychiatry and Psychotherapy at the University of Bonn. She has also served as the Executive Senior Physician at the Department of Psychiatry and Psychotherapy at the University of Freiburg. Her expertise in ADHD has led to research on its etiology, symptomatology, and therapy in adults. Dr. Philipsen has also supervised cognitive behavior therapy and dialectical behavior therapy. Her scientific focus is translational therapy research on attention and emotion regulation, development, and evaluation of pharmacological and non-pharmacological treatments for ADHD in adults including digital tools. Her clinical focus is diagnosis and treatment of the entire spectrum of mental disorders, especially affective disorders such as depression, stress-associated disorders, ADHD in adulthood and personality disorders, crisis intervention and suicidality. Dr. Philipsen is the scientific advisor of ADHS-Deutschland, a member of the steering board of the German ADHD Network, a member of the Advisory Board on Psychotherapy, Germany. She is President-elect, Chair of Psychiatry and Psychotherapy, Germany, ECNP network ADHD.
| |
|
2024 Indigenous Healthcare Award
Apply for CADDRA’s Indigenous Healthcare Award to support in-person attendance at CADDRA’s 20th Annual ADHD Conference.
The applicant must be working with a Canadian Indigenous population and should have an interest in ADHD.
The Award
- Registration to CADDRA Conference 2024
- CADDRA membership for one year
- $1,500 travel support*
Deadline for applications is JULY 31, 2024.
*Award recipient will be required to make their own travel and accommodation arrangements.
APPLY HERE
| |
|
2024 CADDRA Student Conference Awards
This award offers an opportunity for five students / residents / trainees to attend CADDRA’s two-day 2024 Conference by providing complimentary registration.
Deadline for applications is JULY 31, 2024.
APPLY HERE
| |
|
KBHN/CADDRA Trainee Researcher Awards
We are excited to announce that Kids Brain Health Network (KBHN), for the seventh consecutive year, is generously providing $5,000 towards awards for ten selected oral and poster presentations by student/trainee presenters based on merit.
All trainee researchers who are accepted as an oral or poster presenter at ADHD Research Day are eligible for the awards.
| |
|
New this Year!
ADHD Assessment and Management Primer for Healthcare Professionals
This ADHD primer is for healthcare providers who want to improve their confidence in screening, diagnosing, prescribing and optimizing care for patients with ADHD, including those with co-morbidities.
This will be a full-day event on Friday, September 27.
| |
|
The submission portal is now closed!
Thanks to all who submitted abstracts.
Notice of Acceptance: by June 30, 2024
| |
Plan your downtime using this special CADDRA delegate microsite provided by Tourism Winnipeg. | |
Reserve your Accommodation!
CADDRA 2024 will be hosted at the convenient downtown location of the Fairmont Winnipeg in Winnipeg, Manitoba.
A limited block of rooms has been set aside at a special reduced rate for CADDRA 2024 attendees.
Reserve your room now!
| |
|
Current ADHD Research
Please note: These are links to research abstracts. Some are available without cost and others require a subscription.
| |
|
ADHD Prevalence among US children and adolescents in 2022: Diagnosis, severity, co-occurring disorders, and treatment. Danielson, Melissa L., et al. Journal of Clinical Child & Adolescent Psychology (2024): 1-18.
Pathway from attention-deficit/hyperactivity disorder to suicide/self-harm. Lin, Ping-I., et al. Psychiatry research 337 (2024): 115936.
Racial-Ethnic Differences in ADHD Diagnosis and Treatment During Adolescence and Early Adulthood. Adams, Sydney M., et al. Psychiatric Services (2024): appi-ps.
The management of sleep disturbances in children with attention-deficit/hyperactivity disorder (ADHD): an update of the literature. Cortese, Samuele, et al. Expert Review of Neurotherapeutics (2024): 1-12.
| |
|
New Expert Series Coming Soon to ADHDLearn! | |
|
Members will be notified via email the moment CADDRA Expert Series 2024 is available.
The keynote presentations were recorded at CADDRA’s ADHD Conference held in Montreal, QC in September 2023. They will be available in June as an accredited program.
| |
CADDRA ADHD and Substance Use Program | |
In addition to evidence-based content and clinical insights, the CADDRA ADHD and Substance Use Program (CASUP) will also include resources to support learners in applying the content in practice. This month, we are providing an excerpt from the CASUP Workplace Accommodations checklist for individuals with ADHD and/or SUDs. | |
|
The course will launch in late 2024 on ADHDLearn. Click on the "Get Early Notification" button to receive advance email notification when the course launches. | |
|
|
|
Are You Professionally Involved with ADHD?
Discover the benefits of becoming a member of CADDRA.
FIND OUT MORE
| | | | | | |
